RA patients no. (%) (N= 80) | |
---|---|
RF + ve only | 11(13.8%) |
Anti-CCP +ve only | 10 (12.5%) |
Anti-CarP +ve only | 3 (3.7%) |
RF and anti-CCP +ve | 25 (31.3%) |
RF and anti-CarP +ve | 8 (10%) |
RF, Anti-CCP and anti-CarP +ve | 10 (12,5%) |
Anti-CCP and anti-CarP +ve | 3 (3.8%) |
OPG +ve only | 9 (11.3%) |
OPG and anti-CarP +ve | 3 (3.6%) |
RANKL +ve only | 7 (8.8%) |
RANKL and anti-CarP +ve | 3 (3.7%) |